Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 28 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (15)

Trial Status

Completed8
Not Yet Recruiting7
Recruiting6
Unknown6
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (28)

Showing 20 of 20 trials
NCT06620432Not ApplicableRecruitingPrimary

High vs. Low Segmental Hysterotomy: Impact on Uterine Wall Defects Post-Cesarean

NCT07520201Not ApplicableNot Yet RecruitingPrimary

Comparison Between 3 Conservative Surgeries for Placenta Accreta Spectrum

NCT07519993Not ApplicableNot Yet RecruitingPrimary

Conservative Management of Placenta Accreta Spectrum Using Kasr Al-Ainy Technique With or Without Hayman Sutures

NCT07452185Not Yet RecruitingPrimary

Evaluation of Cervical Invasion and Length in Placenta Accreta Patients

NCT07421180CompletedPrimary

Maternal Serum Adropin in Placenta Accreta Spectrum

NCT07406841Not Yet RecruitingPrimary

Spinal Versus General Anesthesia in Pregnancies With Placenta Accreta Spectrum: A Retrospective Comparative Study

NCT07129135Not ApplicableCompletedPrimary

Effect of Methylene Blue Bladder Instillation on Urinary Tract Injuries During Cesarean Hysterectomy for Placenta Accreta Spectrum

NCT07025954Not ApplicableRecruiting

Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta

NCT06562712Not ApplicableCompleted

Evaluation of Bilateral Internal Iliac Artery Balloon Occlusion in Placenta Accreta Spectrum Management

NCT06512181Not ApplicableRecruitingPrimary

Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders

NCT06867874Not ApplicableRecruiting

Syncytiotrophoblast-derived Extracellular Vesicles in Placenta Previa and Accreta Spectrum

NCT04866888Not ApplicableRecruitingPrimary

Placenta Accreta Spectrum Outcome After Uterine Conservation

NCT06808165CompletedPrimary

Relaxin and Placental Volume in Placenta Accreta Spectrum

NCT06721182Not ApplicableNot Yet RecruitingPrimary

Effectiveness of REBOA in Reducing Blood Loss During Cesarean Section in Patients with PAS

NCT06493968Not ApplicableRecruitingPrimary

Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy

NCT06483724Not ApplicableNot Yet RecruitingPrimary

Comparison Between Cervical Tourniquet and Uterine Artery Ligation Prior to Segmental Resection Approach

NCT06477497Not Yet RecruitingPrimary

The Application of Comprehensive Prevention and Treatment Strategy of Placenta Accreta Spectrum Disorders

NCT06383923UnknownPrimary

Risk Factors, Prognosis and Prediction Models for Placenta Accreta Without Prior Cesarean Section

NCT06356493Completed

Prophylactic Occlusion Balloons of Both Internal Iliac Arteries in Caesarean Hysterectomy for PASD

NCT04427592Not ApplicableCompletedPrimary

New Conservative Technique for Placenta Accreta Spectrum

Scroll to load more

Research Network

Activity Timeline